Management of Recurrent Odynophagia in Kidney Transplant Recipients
Immediate Diagnostic Workup
- Perform upper endoscopy with biopsy and culture to definitively diagnose esophageal candidiasis, HSV esophagitis, or CMV esophagitis in immunosuppressed transplant recipients who have failed antibacterial therapy. 1
- Obtain CMV viral load by nucleic acid testing (NAT) or pp65 antigenemia to assess for CMV disease. 1
- Conduct HSV PCR testing when vesicular lesions are present or endoscopic findings suggest HSV infection. 2
Empiric Antifungal Therapy While Awaiting Endoscopy
- Start oral fluconazole 200–400 mg daily empirically for presumed esophageal candidiasis, the most common cause of odynophagia in this population. 1
- Use intravenous fluconazole 400 mg daily if the patient cannot tolerate oral intake or has severe symptoms. 1
- Continue antifungal therapy for at least 14–21 days once candidiasis is confirmed. 1
Immunosuppression Adjustment
- Reduce the mycophenolate dose by approximately 50 % temporarily until the infection resolves; this is the first‑line adjustment for serious infections in transplant recipients. 4
- Keep calcineurin inhibitor (tacrolimus or cyclosporine) within the low therapeutic range during active infection. 4
- Monitor tacrolimus/cyclosporine levels closely because fluconazole can raise calcineurin inhibitor concentrations via CYP3A4 inhibition. 1
Alternative Diagnoses and Targeted Therapy
- If odynophagia persists after 7 days of fluconazole, proceed urgently to endoscopy to evaluate for HSV or CMV esophagitis. 2
- For confirmed HSV esophagitis, treat with oral acyclovir 400 mg five times daily or valacyclovir 1 g three times daily for 14–21 days. 2
- For systemic or severe HSV disease, use intravenous acyclovir 5–10 mg/kg every 8 hours and further reduce immunosuppression. 2
- For confirmed CMV esophagitis, administer intravenous ganciclovir 5 mg/kg twice daily or oral valganciclovir 900 mg twice daily. 1
- Continue CMV therapy until plasma CMV is no longer detectable by NAT. 1
Monitoring During Treatment
- Check CMV viral load weekly when CMV disease has been diagnosed. 1
Critical Pitfalls to Avoid
- Do not extend antibacterial therapy beyond the initial failed course; persistent odynophagia after amoxicillin‑clavulanate suggests a fungal or viral etiology. 1
- Avoid excessive reduction of immunosuppression that could precipitate acute rejection, while recognizing that life‑threatening infections may necessitate temporary dose reductions. 5